| Albert David Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524075 |
NSE Symbol : ALBERTDAVD |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE155C01010 |
Div & Yield% : 0.69 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 685.71 |
Market Cap(₹Cr) : 413.32 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 101.34 | 85.86 | 89.93 | 87.24 | 70.57 | 74.89 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 101.34 | 85.86 | 89.93 | 87.24 | 70.57 | 74.89 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 27.96 | -24.84 | 12.40 | -2.14 | 22.04 | -5.11 |
| Total Income | 129.30 | 61.03 | 102.33 | 85.10 | 92.60 | 69.78 |
| Total Expenditure | 90.70 | 83.11 | 79.10 | 84.70 | 81.22 | 79.64 |
| PBIDT | 38.60 | -22.08 | 23.22 | 0.40 | 11.38 | -9.86 |
| Interest | 0.52 | 0.43 | 0.90 | 0.75 | 0.55 | 0.13 |
| PBDT | 38.08 | -22.51 | 22.33 | -0.35 | 10.83 | -9.99 |
| Depreciation | 2.29 | 2.72 | 2.42 | 2.23 | 2.39 | 1.82 |
| Tax | 1.20 | 0.19 | 3.11 | 0.00 | 0.00 | 1.79 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.60 | -3.99 | 1.49 | 0.72 | 0.50 | -3.27 |
| Reported Profit After Tax | 32.00 | -21.43 | 15.30 | -3.30 | 7.94 | -10.33 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 32.00 | -21.43 | 15.30 | -3.30 | 7.94 | -10.33 |
| EPS (Unit Curr.) | 56.07 | -37.56 | 26.81 | -5.79 | 13.91 | -18.10 |
| EPS (Adj) (Unit Curr.) | 56.07 | -37.56 | 26.81 | -5.79 | 13.91 | -18.10 |
| Calculated EPS (Unit Curr.) | 56.07 | -37.56 | 26.81 | -5.79 | 13.91 | -18.10 |
| Calculated EPS (Adj) (Unit Curr.) | 56.07 | -37.56 | 26.81 | -5.79 | 13.91 | -18.10 |
| Calculated EPS (Ann.) (Unit Curr.) | 224.26 | -150.23 | 107.26 | -23.14 | 55.63 | -72.39 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 224.26 | -150.23 | 107.26 | -23.14 | 55.63 | -72.39 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 38.09 | -25.72 | 25.82 | 0.46 | 16.13 | -13.17 |
| PBDTM(%) | 37.58 | -26.22 | 24.83 | -0.40 | 15.35 | -13.34 |
| PATM(%) | 31.58 | -24.96 | 17.01 | -3.78 | 11.25 | -13.79 |
